Study on the mechanism of Fuzi Lizhong decoction in the treatment of colorectal cancer of spleen kidney deficiency from the perspective of intestinal flora and hypoxia inducible factor-1α signalling pathway.
Fuzi Lizhong decoction effectively improves intestinal microbiota composition, reduces inflammatory factors and HIF-1α expression, alleviates chemotherapy-related adverse reactions, enhances clinical efficacy, and may inhibit tumor growth in patients with colorectal cancer.
Authors
- Ye Zhao (ORCID: https://orcid.org/0000-0001-5969-1203)
- Lu WenJuan
- Lina Zhang (ORCID: https://orcid.org/0000-0002-7742-0252)
- Xin Zhao (ORCID: https://orcid.org/0000-0002-5598-2158)
- Lin Xiu
Institutions
- Krirk University (TH)
Publication Details
- Journal
- PubMed
- Published
- 2025-08-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.04.013
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00